Rhumbline Advisers

Filing Details

13F-HR/A • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-29
Total Holdings
4,182
Total Value
106905259736
Accession Number
0001115418-25-000005
Form Type
13F-HR/A
CIK
0001115418
Manager Name
Rhumbline Advisers
Data Enrichment
81% identified
3,407 identified775 unidentified

Holdings

4,182 positions
Manager:
SEC
Search and click to pin securities to the top
Page 165 of 210
AMES NATIONAL CORP
ATLO|031001100
Shares:
8112(-8.5%)
Value:
$142.1M(-2.4%)
Larimar Therapeutics, Inc.
LRMR|517125100
Shares:
65018(+15.7%)
Value:
$139.8M(-35.7%)
Criteo S.A.
CRTO|226718104
Shares:
3908(-5.5%)
Value:
$138.4M(-15.4%)
93114W107
93114W107
Shares:
4927(-67.5%)
Value:
$135.7M(-66.1%)
Orchestra BioMed Holdings, Inc.
OBIO|68572M106
Shares:
31657(+3.0%)
Value:
$135.5M(+10.2%)
GENCOR INDUSTRIES INC
GENC|368678108
Shares:
11140(-11.9%)
Value:
$135.5M(-39.3%)
scPharmaceuticals Inc.
SCPH|810648105
Shares:
51499(+21.0%)
Value:
$135.4M(-10.1%)
Septerna, Inc.
SEPN|81734D104
Shares:
23318(+16.6%)
Value:
$135.0M(-70.5%)
Zentalis Pharmaceuticals, Inc.
ZNTL|98943L107
Shares:
84542(-8.3%)
Value:
$134.4M(-51.9%)
23346J103
23346J103
Shares:
13610(+24.6%)
Value:
$134.3M(+20.8%)
98887L105
98887L105
Shares:
7671(+78.5%)
Value:
$132.6M(+81.6%)
SMITH MIDLAND CORP
SMID|832156103
Shares:
4265(+9.6%)
Value:
$132.5M(-23.4%)
GERDAU S.A.
GGB|373737105
Shares:
46647(-3.9%)
Value:
$132.5M(-5.2%)
65479L108
65479L108
Shares:
13604(+7.5%)
Value:
$132.4M(-11.7%)
Foghorn Therapeutics Inc.
FHTX|344174107
Shares:
36245(-0.4%)
Value:
$132.3M(-23.0%)
64104Y106
64104Y106
Shares:
28900(-5.5%)
Value:
$131.5M(-31.1%)
Yalla Group Ltd
YALA|98459U103
Shares:
25188(-50.5%)
Value:
$131.5M(-36.3%)
682151303
682151303
Shares:
4658(-5.5%)
Value:
$131.4M(-20.6%)
Opera Ltd
OPRA|68373M107
Shares:
8186(-2.7%)
Value:
$130.5M(-18.1%)
85917W102
85917W102
Shares:
26874(-9.8%)
Value:
$130.1M(-8.3%)